Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of the Neurological Sciences
Journal
Overview
Identity
Overview
Publication Venue For
It's tricky: Rating alleviating maneuvers in cervical dystonia
. 419.
2020
Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke
. 412.
2020
Genetic risk of Spontaneous intracerebral hemorrhage: Systematic review and future directions
. 407.
2019
Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis
. 407.
2019
Epilepsy treatment patterns among patients with tuberous sclerosis complex
. 391:104-108.
2018
Advancing stroke genomic research in the age of Trans-Omics big data science: Emerging priorities and opportunities
. 382:18-28.
2017
Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence
. 380:38-43.
2017
Interleukin–6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men
. 379:229-235.
2017
Caffeine, creatine, GRIN2A and Parkinson's disease progression
. 375:355-359.
2017
Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population
. 375:371-375.
2017
Olfactory ability in normal pressure hydrocephalus as compared to Alzheimer's disease and healthy controls
. 372:217-219.
2017
Physical activity, sedentary behavior, and aerobic capacity in persons with multiple sclerosis
. 372:342-346.
2017
Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis
. 370:277-283.
2016
Dissociation among hemodynamic measures in asymptomatic high grade carotid artery stenosis
. 367:143-147.
2016
Evaluating the single seizure clinic model: Findings from a Canadian Center
. 367:203-210.
2016
Neurogenomics in Africa: Perspectives, progress, possibilities and priorities
. 366:213-223.
2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
. 365:190-198.
2016
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis
. 363:225-231.
2016
Gut microbiota composition and relapse risk in pediatric MS: A pilot study
. 363:153-157.
2016
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis
. 362:121-126.
2016
Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status
. 361:95-100.
2016
Itemized NIHSS subsets predict positive MRI strokes in patients with mild deficits
. 358:221-225.
2015
Pallidal and caudate volumes correlate with walking function in multiple sclerosis
. 354:33-36.
2015
The safety of exercise training in multiple sclerosis: A systematic review
. 343:3-7.
2014
Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis
. 340:50-57.
2014
Investigating the minimal important difference in ambulation in multiple sclerosis: A disconnect between performance-based and patient-reported outcomes?
. 347:268-274.
2014
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores
. 335:169-173.
2013
Dual task cost of walking is related to fall risk in persons with multiple sclerosis
. 335:160-163.
2013
Gait and six-minute walk performance in persons with multiple sclerosis
. 334:72-76.
2013
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale
. 331:102-107.
2013
Physical fitness, walking performance, and gait in multiple sclerosis
. 328:70-76.
2013
Creative innovation with temporal lobe epilepsy and lobectomy
. 324:45-48.
2013
The dynamics of finger tremor in multiple sclerosis is affected by whole body position
. 324:84-89.
2013
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis
. 323:123-127.
2012
Impaired cognitive function in patients with atherosclerotic carotid stenosis and correlation with ultrasound strain measurements
. 322:20-24.
2012
Increasing age at disability milestones among MS patients in the MSBase Registry
. 318:94-99.
2012
Postural control in multiple sclerosis: Effects of disability status and dual task
. 315:44-48.
2012
Implementing clinical trials on an international platform: Challenges and perspectives
. 313:1-6.
2012
Pulse pressure is associated with walking impairment in multiple sclerosis
. 309:105-109.
2011
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium
. 307:22-29.
2011
Anxiety and depression severity are related to right but not left onset Parkinson's disease duration
. 305:131-135.
2011
Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12
. 305:75-79.
2011
Post-streptococcal vasculopathy with evolution to Degos' disease
. 300:157-159.
2011
GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke
. 292:72-76.
2010
Accelerometry in persons with multiple sclerosis: Measurement of physical activity or walking mobility?
. 290:6-11.
2010
Continued validation of the Symptom Inventory in multiple sclerosis
. 285:134-136.
2009
Artistic creativity and DBS: A case report
. 276:138-142.
2009
Creativity in Parkinson's disease as a function of right versus left hemibody onset
. 276:179-183.
2009
Pooled analysis of patients with thunderclap headache evaluated by CT and LP: Is angiography necessary in patients with negative evaluations?
. 276:123-125.
2009
Intravenous thrombolysis followed by intra-arterial thrombolysis and mechanical thrombectomy for the treatment of pediatric ischemic stroke
. 275:151-153.
2008
Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12)
. 268:69-73.
2008
Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic
. 260:267-270.
2007
CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease
. 225:79-83.
2004
Optimizing immunomodulatory therapy for MS patients: An integrated management model
. 201:89-90.
2002
Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis
. 173:32-39.
2000
Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction
. 156:53-58.
1998
Raised serum nitrate and nitrite levels in patients with multiple sclerosis
. 145:77-81.
1997
Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα)
. 138:134-144.
1996
The electroencephalogram in neglect
. 34:343-348.
1977
A memory defect in uremic encephalopathy
. 26:245-249.
1975
Identity
International Standard Serial Number (issn)
0022-510X
Electronic International Standard Serial Number (eissn)
1878-5883